• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猫心脏中1,4 - 二氢吡啶和苯烷基胺类钙通道阻滞剂的负性肌力作用强度与结合参数之间的相关性

Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.

作者信息

Goll A, Glossmann H, Mannhold R

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):303-12. doi: 10.1007/BF00508786.

DOI:10.1007/BF00508786
PMID:3027587
Abstract

Partially purified plasma membranes were prepared from cat ventricle. The purification factors for the calcium channel ligands (+)-3H-PN 200-110, 3H-nimodipine (1,4-dihydropyridines) and (-)-3-H-desmethoxyverapamil (a phenylalkylamine) were 3.1-, 3.4- and 2.9-fold, respectively, whilst beta-adrenoceptors labelled with (-)-3H-dihydroalprenolol were purified 3.0-fold. (+)-3H-PN 200-110 bound to 930 +/- 140 fmol/mg of membrane protein with a dissociation constant of 70 pmol/l at 25 degrees C. Under the same conditions 3H-nimodipine bound to 490 +/- 24 fmol/mg of sites with a KD of 120 pmol/l. (-)-3-H-desmethoxyverapamil bound to 530 +/- 55 fmol/mg of sites with a KD of 2.47 nmol/l. Twelve 1,4-dihydropyridines were evaluated for binding inhibition constants (Ki) with (+)-3H-PN 200-110 and 13 phenylalkylamines with (-)-3-H-desmethoxyverapamil in radioligand binding assays. Of the twelve 1,4-dihydropyridines evaluated (+/-)-nitrendipine was the most potent with a Ki-value of 280 pmol/l, nifedipine had a Ki-value of 500 pmol/l and the weakest drug tested, (+/-)-Bay b 4328, had a Ki-value of 14.3 nmol/l. The EC50-values of the same 1,4-dihydropyridines to inhibit the electrically driven cat papillary muscle were 77- to 3,450-fold higher and little correlation existed between Ki and EC50-values. Thirteen phenylalkylamines were tested for their potency to inhibit (-)-3-H-desmethoxyverapamil binding. The most potent phenylalkylamine with respect to negative inotropy was (+/-)-D 595 with an EC50-value of 794 nmol/l, the least potent substance was (+/-)-Sz 45 with an EC50-value of 39.8 mumol/l. The binding inhibition constants for the phenylalkylamines were 13- to 322-fold lower than the values for negative inotropy, but a significant positive correlation between the Ki and EC50-values (n = 12, r = 0.84) was observed. The absolute differences may reflect the state-dependent binding of phenylalkylamines to the channel. QSAR analysis revealed nearly identical correlations between physicochemical substituent properties on the one hand and binding affinities or functional potency on the other hand. In both cases the electronic properties (F-constant) of ring substituents mainly determine the variance in potency.

摘要

从猫心室制备了部分纯化的质膜。钙通道配体(+)-3H-PN 200-110、3H-尼莫地平(1,4-二氢吡啶)和(-)-3-H-去甲氧基维拉帕米(一种苯烷基胺)的纯化因子分别为3.1倍、3.4倍和2.9倍,而用(-)-3H-二氢阿普洛尔标记的β-肾上腺素受体纯化了3.0倍。(+)-3H-PN 200-110在25℃下以70 pmol/L的解离常数与930±140 fmol/mg的膜蛋白结合。在相同条件下,3H-尼莫地平以120 pmol/L的KD与490±24 fmol/mg的位点结合。(-)-3-H-去甲氧基维拉帕米以2.47 nmol/L的KD与530±55 fmol/mg的位点结合。在放射性配体结合试验中,评估了12种1,4-二氢吡啶与(+)-3H-PN 200-110的结合抑制常数(Ki)以及13种苯烷基胺与(-)-3-H-去甲氧基维拉帕米的结合抑制常数。在所评估的12种1,4-二氢吡啶中,(±)-尼群地平最有效,Ki值为280 pmol/L,硝苯地平的Ki值为500 pmol/L,测试的最弱药物(±)-Bay b 4328的Ki值为14.3 nmol/L。相同的1,4-二氢吡啶抑制电驱动猫乳头肌的EC50值高77至3450倍,且Ki与EC50值之间几乎没有相关性。测试了13种苯烷基胺抑制(-)-3-H-去甲氧基维拉帕米结合的效力。对负性肌力作用最有效的苯烷基胺是(±)-D 595,EC50值为794 nmol/L,效力最低的物质是(±)-Sz 45,EC50值为39.8 μmol/L。苯烷基胺的结合抑制常数比负性肌力作用的值低13至322倍,但观察到Ki与EC50值之间存在显著正相关(n = 12,r = 0.84)。绝对差异可能反映了苯烷基胺与通道的状态依赖性结合。定量构效关系分析表明,一方面物理化学取代基性质与另一方面结合亲和力或功能效力之间存在几乎相同的相关性。在这两种情况下,环取代基的电子性质(F常数)主要决定了效力的差异。

相似文献

1
Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.猫心脏中1,4 - 二氢吡啶和苯烷基胺类钙通道阻滞剂的负性肌力作用强度与结合参数之间的相关性
Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):303-12. doi: 10.1007/BF00508786.
2
Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium.人心室肌中β-肾上腺素能受体与钙通道的关系。
Br J Pharmacol. 1987 Mar;90(3):447-57. doi: 10.1111/j.1476-5381.1987.tb11194.x.
3
Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.牛心肌肌膜中尼莫地平和(-)-去甲氧基维拉帕米结合位点的表征
Eur J Biochem. 1985 Jul 15;150(2):313-22. doi: 10.1111/j.1432-1033.1985.tb09023.x.
4
The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site.苯烷基胺类钙通道阻滞剂与1,4-二氢吡啶结合位点的相互作用。
J Mol Cell Cardiol. 1986 Sep;18(9):963-74. doi: 10.1016/s0022-2828(86)80010-4.
5
Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.兔心肌中1,4 - 二氢吡啶类钙通道阻滞剂的结合亲和力与负性肌力效能比较
J Pharmacol Exp Ther. 1987 Oct;243(1):118-25.
6
(-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.(-)-[³H]去甲氧基维拉帕米标记脑和骨骼肌膜中的多种钙通道调节剂受体:通过温度和二氢吡啶进行区分。
J Pharmacol Exp Ther. 1986 Jun;237(3):731-8.
7
SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.SR 33557,一种新型钙拮抗剂:与脑膜中[3H] -(±)-尼群地平及[3H] -(-)-去甲氧基维拉帕米结合位点的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):31-6. doi: 10.1007/BF00165122.
8
(-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites.脑内假定钙通道的(-)-3H-去甲氧基维拉帕米标记:放射自显影分布及与1,4-二氢吡啶和地尔硫䓬结合位点的变构偶联
Naunyn Schmiedebergs Arch Pharmacol. 1984 Sep;327(2):183-7. doi: 10.1007/BF00500915.
9
Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.鸡心膜中钙通道激活剂和抑制剂与二氢吡啶受体结合特性的分析。
Circ Res. 1987 Sep;61(3):379-88. doi: 10.1161/01.res.61.3.379.
10
Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.豚鼠海马体中钙通道相关的1,4 - 二氢吡啶和苯烷基胺受体的光亲和标记。一种195 kDa的多肽同时携带这两种药物受体,并且与纯化的骨骼肌钙通道的α1亚基具有相似性。
Biochem J. 1988 Jul 1;253(1):39-47. doi: 10.1042/bj2530039.

引用本文的文献

1
Structural model for phenylalkylamine binding to L-type calcium channels.苯烷基胺与L型钙通道结合的结构模型。
J Biol Chem. 2009 Oct 9;284(41):28332-28342. doi: 10.1074/jbc.M109.027326. Epub 2009 Aug 21.
2
Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study.钙拮抗剂维拉帕米的半刚性类似物:一项分子建模研究。
J Comput Aided Mol Des. 1994 Apr;8(2):123-34. doi: 10.1007/BF00119863.
3
Stereoisomers of calcium antagonists discriminate between coronary vascular and myocardial sites.钙拮抗剂的立体异构体可区分冠状动脉血管部位和心肌部位。

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
The effects of nimodipine, its optical isomers and metabolites on isolated vascular smooth muscle.尼莫地平及其光学异构体和代谢产物对离体血管平滑肌的作用。
Arzneimittelforschung. 1982;32(4):338-46.
3
[3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.[3H]-尼群地平,一种强效钙拮抗剂,与心肌膜具有高亲和力结合。
Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):213-9. doi: 10.1007/BF00169250.
4
Characteristics of the phenylalkylamine binding site in canine cardiac sarcolemmal membranes.
Basic Res Cardiol. 1988 Jul-Aug;83(4):369-75. doi: 10.1007/BF02005822.
5
Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.骨骼肌Ca2+通道α1亚基内苯烷基胺结合区域的鉴定。
Proc Natl Acad Sci U S A. 1990 Dec;87(23):9108-12. doi: 10.1073/pnas.87.23.9108.
6
The influence of 3-ester side chain variation on the cardiovascular profile of nitrendipine in porcine isolated trabeculae and coronary arteries.3-酯侧链变异对尼群地平在猪离体小梁和冠状动脉中心血管特征的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1991 Oct;344(4):488-94. doi: 10.1007/BF00172590.
Arzneimittelforschung. 1981;31(12):2064-7.
4
Stereoselective and non-stereoselective effects of D 600 (methoxyverapamil) in smooth muscle preparations.D600(甲氧维拉帕米)在平滑肌制剂中的立体选择性和非立体选择性作用。
Eur J Pharmacol. 1981 Nov 19;76(1):67-72. doi: 10.1016/0014-2999(81)90010-8.
5
The influence of aromatic substitution on the negative inotropic action of verapamil in the isolated cat papillary muscle.芳香取代对维拉帕米在离体猫乳头肌中负性肌力作用的影响。
Arzneimittelforschung. 1981;31(5):773-80.
6
Binding of [3H]nimodipine to cardiac and smooth muscle membranes.[3H]尼莫地平与心肌和平滑肌细胞膜的结合。
Eur J Pharmacol. 1982 Aug 27;82(3-4):191-4. doi: 10.1016/0014-2999(82)90511-8.
7
Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.药物在钾离子去极化平滑肌中“钙离子拮抗剂”作用的评估。拮抗剂亚组的区分。
Naunyn Schmiedebergs Arch Pharmacol. 1982 Feb;318(3):234-40. doi: 10.1007/BF00500485.
8
Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.钙离子通道拮抗剂[3H]尼群地平与豚鼠回肠平滑肌结合的特性研究
J Pharmacol Exp Ther. 1983 May;225(2):291-309.
9
Calculating the dissociation constant of an unlabeled compound from the concentration required to displace radiolabel binding by 50%.
J Cyclic Nucleotide Res. 1982;8(3):163-72.
10
Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.钙通道拮抗剂维拉帕米和地尔硫䓬对大鼠脑突触体中[³H]尼群地平结合的温度依赖性调节
J Pharmacol Exp Ther. 1984 May;229(2):333-9.